COVID-19: FDA Expands List Of Remote Monitoring Devices That Don’t Need Premarket Notification

The US agency has added gaseous-phase carbon-dioxide gas analyzers to its list of products that – during the coronavirus pandemic – will not require a new premarket notification to be marketed for remote monitoring.

Guidance word in red keyboard buttons

The US Food and Drug Administration on 28 October updated a guidance document it released earlier this year to allow certain remote monitoring devices on the market without the need for a premarket notification. It includes more standards and devices that the agency says is meant to minimize patient-physician interaction during the coronavirus pandemic.

The FDA in March published the emergency guidance, “Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

As Medtech Tariffs Loom, AdvaMed Responds With Its Own Plan Emphasizing ‘Reciprocal’ Free Trade

 

The US Department of Commerce’s investigation into the national security impact of importing various medical equipment could lead to tariffs on many products. Device industry responds by emphasizing the robustness of domestic production, but also the rigidity of supply and reimbursement agreements.

Persistence Pays Off: New International Clinical Evaluation Standard Is Finally On Horizon

 

Clinical evaluation and standards expert Danielle Giroud celebrates progress on the document and looks at what it means internationally and for the EU.

German Medtechs Choking Under EU Compliance And Reporting Obligations Tout Mutual Recognition

 
• By 

Industry survey points to ongoing low revenues rise and weaker profit levels for half of BVMed industry association members in 2025, as German manufacturers raise stakes on global harmonization.

Fixing The Fractures: New Aspirations For EU Medtech Regulatory Progress

 

A pioneering initiative, Edvance MedTech, is being launched by leading experts in medical technology regulation which aims get to the heart of what is needed to improve the way EU rules are not only applied but also decided.

More from Policy & Regulation

German Medtechs Choking Under EU Compliance And Reporting Obligations Tout Mutual Recognition

 
• By 

Industry survey points to ongoing low revenues rise and weaker profit levels for half of BVMed industry association members in 2025, as German manufacturers raise stakes on global harmonization.

Fixing The Fractures: New Aspirations For EU Medtech Regulatory Progress

 

A pioneering initiative, Edvance MedTech, is being launched by leading experts in medical technology regulation which aims get to the heart of what is needed to improve the way EU rules are not only applied but also decided.

MedTech Innovator Winner Armor Medical Hopes To Reduce 90% Of Preventable Maternal Deaths

 
• By 

Armor Medical’s wrist-worn wearable detected postpartum hemorrhage five times earlier than standard care in earlier studies. After surviving near-fatal hemorrhage herself, co-founder/CEO Kelsey Mayo aims to bring the device to market in 2028.